• 1. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 2. Evolution in surface coverage of CH3NH3PbI3?XClXvia heat assisted solvent vapour treatment and their effects on photovoltaic performance of devices
  Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738
• 3. Estimation of activation energy for electroporation and pore growth rate in liquid crystalline and gel phases of lipid bilayers using molecular dynamics simulations?
  Amit Kumar Majhi,Subbarao Kanchi,V. Venkataraman,K. G. Ayappa,Prabal K. Maiti Soft Matter, 2015,11, 8632-8640
• 4. Excited state potential energy surfaces and their interactions in FeIVO active sites
  Shaun D. Wong,Edward I. Solomon Dalton Trans., 2014,43, 17567-17577
• 5. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291

Introduction to 4-Bromo-2-fluoro-3-nitropyridine (CAS No. 1805248-79-6)

4-Bromo-2-fluoro-3-nitropyridine, identified by the Chemical Abstracts Service Number (CAS No.) 1805248-79-6, is a fluorinated nitropyridine derivative that has garnered significant attention in the field of pharmaceutical and agrochemical research. This compound serves as a versatile intermediate in the synthesis of various biologically active molecules, particularly in the development of novel therapeutic agents targeting neurological and inflammatory disorders. The unique structural features of this compound, including the presence of both bromo and fluoro substituents, make it an attractive scaffold for medicinal chemists seeking to modulate receptor interactions and enhance drug efficacy.

The bromo and fluoro functional groups in 4-Bromo-2-fluoro-3-nitropyridine contribute to its reactivity and potential biological activity. The bromo group, for instance, can participate in cross-coupling reactions such as Suzuki or Buchwald-Hartwig couplings, enabling the introduction of aryl or heteroaryl groups into the molecule. This property is particularly valuable in constructing complex drug molecules where specific spatial arrangements of functional groups are critical for biological activity. On the other hand, the fluoro substituent is known for its ability to influence metabolic stability, lipophilicity, and binding affinity at biological targets. In particular, fluorine atoms can enhance binding interactions by increasing electronic density and reducing steric hindrance.

Recent advancements in medicinal chemistry have highlighted the importance of fluorinated heterocycles in drug discovery. 4-Bromo-2-fluoro-3-nitropyridine has been employed in the synthesis of kinase inhibitors, which are crucial in treating cancers and inflammatory diseases. The nitro group present in this compound can be further functionalized through reduction to an amine or diazotization to introduce additional reactive sites. These modifications have been exploited in the design of molecules that exhibit potent inhibitory effects on target enzymes. For example, studies have demonstrated that derivatives of 4-Bromo-2-fluoro-3-nitropyridine can selectively inhibit Janus kinases (JAKs), which play a pivotal role in signaling pathways associated with autoimmune diseases.

The utility of 4-Bromo-2-fluoro-3-nitropyridine extends beyond kinase inhibition. Researchers have also explored its application in developing antiviral agents. The structural motif of this compound has been incorporated into molecules designed to interfere with viral replication processes. Specifically, the combination of bromo and fluoro substituents allows for fine-tuning of physicochemical properties such as solubility and cell membrane permeability, which are essential for effective drug delivery. Moreover, computational studies have suggested that fluorinated pyridines can exhibit favorable pharmacokinetic profiles due to their ability to resist metabolic degradation.

In addition to its pharmaceutical applications, 4-Bromo-2-fluoro-3-nitropyridine has shown promise in agrochemical research. Fluorinated pyridines are widely used in crop protection chemicals due to their stability and efficacy against pests and pathogens. Derivatives of this compound have been investigated as potential herbicides and fungicides, where their structural flexibility allows for targeted interaction with biological systems without harming non-target organisms. The nitro group further enhances their reactivity, enabling modifications that improve environmental compatibility while maintaining high efficacy.

The synthesis of 4-Bromo-2-fluoro-3-nitropyridine typically involves multi-step organic transformations starting from commercially available pyridine precursors. A common synthetic route includes halogenation followed by nitration and subsequent functional group manipulation. The precise control over reaction conditions is crucial to achieving high yields and purity, as side reactions can lead to undesired byproducts that may complicate downstream applications. Advances in catalytic methods have also enabled more efficient synthetic pathways, reducing the environmental impact of production processes.

From a regulatory perspective, compounds like 4-Bromo-2-fluoro-3-nitropyridine must undergo rigorous testing to ensure safety and efficacy before they can be commercialized for therapeutic or agricultural use. Preclinical studies are essential to evaluate their pharmacological properties, including mechanism of action, toxicity profiles, and pharmacokinetic behavior. These studies often involve both in vitro assays using cellular models and in vivo experiments involving animal models to assess potential therapeutic benefits and risks.

The growing interest in fluorinated compounds underscores their significance in modern drug discovery. The unique electronic properties imparted by fluorine atoms make them invaluable for designing molecules with enhanced binding affinity and metabolic stability. As research continues to uncover new applications for compounds like 4-Bromo-2-fluoro-3-nitropyridine, their role in developing next-generation therapeutics is likely to expand further.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)